MERI NISIMOVA: Open Payments
NPI 1124063219 · RICHMOND HILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 16 payments from 6 companies in 2025. Trend: 2023 $633 · 2024 $1,056 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $328 |
| Teva Pharmaceuticals USA, Inc. | 4 | $187 |
| Alkermes, Inc. | 3 | $186 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| ABBVIE INC. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: ABILIFY MAINTENA, UZEDY, ARISTADA, INVEGA SUSTENNA, VRAYLAR, CAPLYTA.
Industry payments across NY — which companies pay providers there.
